 Kristine Kuhn
Concepts (302)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spondylarthritis | 16 | 2025 | 50 | 7.110 |
Why?
| | Gastrointestinal Microbiome | 18 | 2025 | 697 | 4.530 |
Why?
| | Arthritis, Rheumatoid | 20 | 2025 | 1167 | 4.290 |
Why?
| | Microbiota | 13 | 2025 | 762 | 3.750 |
Why?
| | Spondylitis, Ankylosing | 6 | 2022 | 46 | 2.950 |
Why?
| | Arthritis, Experimental | 8 | 2025 | 147 | 2.880 |
Why?
| | Immunity, Mucosal | 7 | 2025 | 97 | 2.140 |
Why?
| | Intraepithelial Lymphocytes | 3 | 2024 | 15 | 2.010 |
Why?
| | Intestinal Mucosa | 8 | 2025 | 623 | 1.990 |
Why?
| | Inflammatory Bowel Diseases | 11 | 2025 | 351 | 1.990 |
Why?
| | Dysbiosis | 5 | 2025 | 181 | 1.670 |
Why?
| | Intestines | 5 | 2021 | 357 | 1.660 |
Why?
| | Crohn Disease | 5 | 2025 | 243 | 1.650 |
Why?
| | Interleukin-17 | 3 | 2023 | 119 | 1.570 |
Why?
| | Colon | 5 | 2025 | 282 | 1.530 |
Why?
| | Arthritis | 4 | 2022 | 95 | 1.480 |
Why?
| | Autoimmune Diseases | 4 | 2024 | 460 | 1.110 |
Why?
| | Rheumatology | 3 | 2024 | 118 | 1.100 |
Why?
| | Th17 Cells | 3 | 2025 | 108 | 1.060 |
Why?
| | Inflammation | 11 | 2025 | 2837 | 1.040 |
Why?
| | Bacteria | 4 | 2025 | 858 | 0.970 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2024 | 99 | 0.960 |
Why?
| | Autoantibodies | 7 | 2025 | 1496 | 0.950 |
Why?
| | Pentanols | 1 | 2024 | 5 | 0.900 |
Why?
| | Butyrates | 2 | 2024 | 61 | 0.900 |
Why?
| | Lyases | 1 | 2024 | 12 | 0.890 |
Why?
| | Arthritis, Juvenile | 1 | 2025 | 56 | 0.890 |
Why?
| | Sphingosine | 1 | 2024 | 46 | 0.860 |
Why?
| | Lysophospholipids | 1 | 2024 | 80 | 0.840 |
Why?
| | Tryptophan | 2 | 2023 | 183 | 0.820 |
Why?
| | Musculoskeletal Diseases | 1 | 2024 | 78 | 0.810 |
Why?
| | Myeloid Cells | 1 | 2024 | 148 | 0.800 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2024 | 336 | 0.770 |
Why?
| | Animals | 32 | 2025 | 36940 | 0.750 |
Why?
| | Interleukin-6 | 3 | 2017 | 778 | 0.740 |
Why?
| | T-Lymphocytes | 3 | 2021 | 1996 | 0.710 |
Why?
| | Immunoglobulin A | 1 | 2022 | 211 | 0.710 |
Why?
| | Mice | 24 | 2025 | 17787 | 0.710 |
Why?
| | Mice, Knockout | 3 | 2025 | 3015 | 0.650 |
Why?
| | Biomedical Research | 2 | 2024 | 692 | 0.650 |
Why?
| | Mentoring | 1 | 2022 | 149 | 0.640 |
Why?
| | Metabolomics | 3 | 2025 | 678 | 0.640 |
Why?
| | Metagenomics | 1 | 2021 | 169 | 0.630 |
Why?
| | Humans | 57 | 2025 | 137585 | 0.560 |
Why?
| | Bacteroidaceae | 1 | 2017 | 3 | 0.560 |
Why?
| | Citrobacter rodentium | 1 | 2017 | 7 | 0.550 |
Why?
| | Osteoarthritis | 1 | 2020 | 185 | 0.550 |
Why?
| | Enterobacteriaceae Infections | 1 | 2017 | 43 | 0.530 |
Why?
| | Skin | 2 | 2020 | 752 | 0.480 |
Why?
| | Gastrointestinal Tract | 1 | 2018 | 195 | 0.470 |
Why?
| | Disease Models, Animal | 10 | 2025 | 4295 | 0.460 |
Why?
| | Collagen Type II | 2 | 2018 | 53 | 0.430 |
Why?
| | Collagen | 4 | 2023 | 452 | 0.420 |
Why?
| | Cytokines | 7 | 2025 | 2085 | 0.390 |
Why?
| | Anti-Citrullinated Protein Antibodies | 3 | 2024 | 115 | 0.380 |
Why?
| | Colitis | 3 | 2025 | 266 | 0.380 |
Why?
| | Antirheumatic Agents | 2 | 2024 | 293 | 0.360 |
Why?
| | Antigens | 2 | 2013 | 357 | 0.340 |
Why?
| | Receptors, Complement 3d | 2 | 2008 | 141 | 0.330 |
Why?
| | RNA, Ribosomal, 16S | 4 | 2025 | 549 | 0.320 |
Why?
| | Mice, Inbred DBA | 4 | 2024 | 200 | 0.310 |
Why?
| | Immunity, Innate | 3 | 2020 | 828 | 0.310 |
Why?
| | Germ-Free Life | 4 | 2025 | 34 | 0.290 |
Why?
| | Receptors, Complement 3b | 1 | 2008 | 84 | 0.280 |
Why?
| | Biomarkers | 4 | 2024 | 4149 | 0.280 |
Why?
| | HLA-B27 Antigen | 2 | 2024 | 16 | 0.270 |
Why?
| | Mice, Inbred C57BL | 8 | 2025 | 5757 | 0.270 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1430 | 0.270 |
Why?
| | Cell Proliferation | 1 | 2014 | 2475 | 0.260 |
Why?
| | Feces | 4 | 2025 | 484 | 0.250 |
Why?
| | Bacterial Translocation | 1 | 2025 | 43 | 0.230 |
Why?
| | Phytochemicals | 1 | 2025 | 13 | 0.230 |
Why?
| | Tea | 1 | 2025 | 21 | 0.230 |
Why?
| | Symbiosis | 2 | 2017 | 79 | 0.230 |
Why?
| | Hexanols | 1 | 2024 | 4 | 0.230 |
Why?
| | Arthritis, Psoriatic | 1 | 2024 | 21 | 0.230 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 37 | 0.230 |
Why?
| | Hypoxia-Inducible Factor 1 | 2 | 2015 | 72 | 0.230 |
Why?
| | Peptides, Cyclic | 1 | 2006 | 259 | 0.220 |
Why?
| | Methylamines | 1 | 2024 | 34 | 0.220 |
Why?
| | Fingolimod Hydrochloride | 1 | 2024 | 40 | 0.220 |
Why?
| | Ileitis | 1 | 2023 | 32 | 0.210 |
Why?
| | Choline | 1 | 2024 | 127 | 0.210 |
Why?
| | Colitis, Ulcerative | 1 | 2025 | 136 | 0.200 |
Why?
| | Congresses as Topic | 1 | 2024 | 233 | 0.200 |
Why?
| | Bifidobacterium longum | 1 | 2022 | 6 | 0.200 |
Why?
| | Autoantigens | 2 | 2022 | 430 | 0.190 |
Why?
| | Mucous Membrane | 2 | 2024 | 125 | 0.190 |
Why?
| | Oryza | 1 | 2022 | 33 | 0.190 |
Why?
| | Erythema Nodosum | 1 | 2022 | 8 | 0.190 |
Why?
| | Pyoderma Gangrenosum | 1 | 2022 | 9 | 0.190 |
Why?
| | Disease Susceptibility | 2 | 2021 | 347 | 0.190 |
Why?
| | Case-Control Studies | 2 | 2021 | 3556 | 0.190 |
Why?
| | Granzymes | 1 | 2021 | 50 | 0.180 |
Why?
| | United States | 5 | 2025 | 14841 | 0.170 |
Why?
| | Uveitis | 1 | 2022 | 136 | 0.170 |
Why?
| | Mentors | 1 | 2022 | 202 | 0.170 |
Why?
| | Cell Differentiation | 2 | 2024 | 1991 | 0.160 |
Why?
| | Metabolic Networks and Pathways | 1 | 2021 | 180 | 0.160 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 185 | 0.160 |
Why?
| | Bacteriophages | 1 | 2021 | 98 | 0.160 |
Why?
| | Bacteroides | 2 | 2019 | 21 | 0.160 |
Why?
| | Glucose Intolerance | 1 | 2021 | 146 | 0.160 |
Why?
| | Risk Factors | 5 | 2025 | 10388 | 0.150 |
Why?
| | Fatty Acids, Volatile | 2 | 2018 | 56 | 0.150 |
Why?
| | Adaptive Immunity | 1 | 2020 | 165 | 0.150 |
Why?
| | Disease | 1 | 2019 | 98 | 0.150 |
Why?
| | Homeodomain Proteins | 1 | 2022 | 506 | 0.150 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2021 | 328 | 0.150 |
Why?
| | Male | 18 | 2025 | 67762 | 0.150 |
Why?
| | Epithelial Cells | 2 | 2015 | 1096 | 0.150 |
Why?
| | Mice, Transgenic | 2 | 2022 | 2167 | 0.140 |
Why?
| | Immunoglobulin G | 1 | 2022 | 893 | 0.140 |
Why?
| | Immune System | 1 | 2019 | 177 | 0.140 |
Why?
| | Vascular Diseases | 1 | 2021 | 243 | 0.140 |
Why?
| | Lymphocytes | 1 | 2020 | 397 | 0.140 |
Why?
| | Monocytes | 1 | 2020 | 563 | 0.140 |
Why?
| | HIV | 1 | 2019 | 234 | 0.140 |
Why?
| | Homosexuality, Male | 1 | 2019 | 184 | 0.140 |
Why?
| | Immune Tolerance | 1 | 2020 | 363 | 0.140 |
Why?
| | Cell Membrane Permeability | 1 | 2017 | 78 | 0.140 |
Why?
| | Female | 17 | 2025 | 73304 | 0.130 |
Why?
| | Pilot Projects | 1 | 2022 | 1710 | 0.130 |
Why?
| | Obesity | 2 | 2021 | 2992 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 606 | 0.130 |
Why?
| | Computational Biology | 1 | 2021 | 644 | 0.130 |
Why?
| | Antibody Formation | 2 | 2008 | 298 | 0.120 |
Why?
| | Sulfatases | 1 | 2015 | 4 | 0.120 |
Why?
| | Secretory Vesicles | 1 | 2015 | 23 | 0.120 |
Why?
| | Claudin-1 | 1 | 2015 | 15 | 0.120 |
Why?
| | Histones | 1 | 2020 | 636 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 279 | 0.120 |
Why?
| | Tight Junctions | 1 | 2015 | 76 | 0.110 |
Why?
| | Molecular Mimicry | 1 | 2014 | 42 | 0.110 |
Why?
| | Antigens, Bacterial | 1 | 2015 | 127 | 0.110 |
Why?
| | Autoimmunity | 3 | 2020 | 908 | 0.110 |
Why?
| | Software | 1 | 2019 | 665 | 0.110 |
Why?
| | Pandemics | 1 | 2022 | 1639 | 0.110 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1774 | 0.110 |
Why?
| | Homeostasis | 1 | 2017 | 621 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1483 | 0.100 |
Why?
| | Middle Aged | 11 | 2025 | 33479 | 0.100 |
Why?
| | Adult | 11 | 2025 | 37929 | 0.100 |
Why?
| | Genome-Wide Association Study | 1 | 2020 | 1431 | 0.100 |
Why?
| | Rheumatologists | 2 | 2023 | 16 | 0.100 |
Why?
| | Physicians | 1 | 2021 | 910 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1809 | 0.090 |
Why?
| | Wound Healing | 1 | 2014 | 331 | 0.090 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 364 | 0.090 |
Why?
| | Asthma | 1 | 2024 | 2295 | 0.090 |
Why?
| | Biopsy | 1 | 2014 | 1129 | 0.090 |
Why?
| | Citrulline | 2 | 2008 | 45 | 0.080 |
Why?
| | Cohort Studies | 4 | 2025 | 5742 | 0.080 |
Why?
| | Carcinogenesis | 2 | 2022 | 217 | 0.080 |
Why?
| | Rheumatoid Factor | 2 | 2008 | 175 | 0.080 |
Why?
| | Porphyromonas gingivalis | 1 | 2008 | 23 | 0.070 |
Why?
| | Freund's Adjuvant | 1 | 2008 | 18 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2025 | 5472 | 0.070 |
Why?
| | Periodontitis | 1 | 2008 | 53 | 0.070 |
Why?
| | Antibodies, Bacterial | 1 | 2008 | 146 | 0.070 |
Why?
| | HIV Infections | 2 | 2019 | 2836 | 0.070 |
Why?
| | Joints | 1 | 2008 | 105 | 0.070 |
Why?
| | Complement C3 | 1 | 2008 | 209 | 0.070 |
Why?
| | Immunoglobulin Isotypes | 1 | 2006 | 34 | 0.060 |
Why?
| | Lupus Vulgaris | 1 | 2006 | 5 | 0.060 |
Why?
| | Antigen-Antibody Reactions | 1 | 2006 | 55 | 0.060 |
Why?
| | Antibody Specificity | 1 | 2006 | 189 | 0.060 |
Why?
| | Immunization | 1 | 2008 | 411 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2607 | 0.060 |
Why?
| | Apoptosis | 1 | 2014 | 2553 | 0.060 |
Why?
| | Fibrinogen | 1 | 2006 | 168 | 0.060 |
Why?
| | Synovial Membrane | 1 | 2006 | 117 | 0.060 |
Why?
| | Child | 1 | 2025 | 21935 | 0.060 |
Why?
| | Paneth Cells | 1 | 2023 | 16 | 0.050 |
Why?
| | Cattle | 1 | 2006 | 984 | 0.050 |
Why?
| | Plant Extracts | 1 | 2025 | 202 | 0.050 |
Why?
| | Cholelithiasis | 2 | 1992 | 38 | 0.050 |
Why?
| | Azoxymethane | 1 | 2022 | 20 | 0.050 |
Why?
| | Dextran Sulfate | 1 | 2022 | 83 | 0.050 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 10 | 0.050 |
Why?
| | Lactobacillus | 1 | 2022 | 29 | 0.050 |
Why?
| | Surveys and Questionnaires | 2 | 2025 | 5778 | 0.050 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 55 | 0.050 |
Why?
| | B-Lymphocytes | 1 | 2007 | 847 | 0.040 |
Why?
| | Quality of Life | 2 | 2025 | 2892 | 0.040 |
Why?
| | Acetylglucosamine | 1 | 2001 | 13 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2021 | 91 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 402 | 0.040 |
Why?
| | Citrullination | 1 | 2020 | 13 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2021 | 199 | 0.040 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2022 | 327 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2001 | 455 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2020 | 390 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2020 | 318 | 0.040 |
Why?
| | Aged | 5 | 2021 | 23961 | 0.040 |
Why?
| | Chondrocytes | 1 | 2001 | 212 | 0.040 |
Why?
| | Consensus | 1 | 2022 | 683 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2071 | 0.040 |
Why?
| | Buspirone | 1 | 1998 | 3 | 0.040 |
Why?
| | Serotonin Receptor Agonists | 1 | 1998 | 26 | 0.040 |
Why?
| | Killer Cells, Natural | 1 | 2001 | 449 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2001 | 789 | 0.040 |
Why?
| | Lorazepam | 1 | 1998 | 27 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 81 | 0.040 |
Why?
| | Anti-Anxiety Agents | 1 | 1998 | 46 | 0.040 |
Why?
| | Prevalence | 1 | 2025 | 2734 | 0.030 |
Why?
| | Organ Specificity | 1 | 2018 | 305 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2020 | 513 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2019 | 337 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 2001 | 496 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2018 | 242 | 0.030 |
Why?
| | Age Factors | 1 | 2025 | 3295 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2019 | 1092 | 0.030 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 200 | 0.030 |
Why?
| | Time Factors | 2 | 2006 | 6828 | 0.030 |
Why?
| | Phylogeny | 1 | 2021 | 904 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2001 | 965 | 0.030 |
Why?
| | Mitochondria | 1 | 2023 | 948 | 0.030 |
Why?
| | Smoking | 1 | 2025 | 1627 | 0.030 |
Why?
| | Procollagen | 1 | 1976 | 23 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 138 | 0.030 |
Why?
| | Genes, Bacterial | 1 | 2015 | 164 | 0.030 |
Why?
| | Sexual Behavior | 1 | 2019 | 485 | 0.030 |
Why?
| | Anxiety Disorders | 1 | 1998 | 377 | 0.030 |
Why?
| | Qualitative Research | 1 | 2021 | 1386 | 0.030 |
Why?
| | Diet | 1 | 2022 | 1278 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2015 | 375 | 0.030 |
Why?
| | Adiposity | 1 | 2018 | 518 | 0.030 |
Why?
| | Gene Deletion | 1 | 2015 | 391 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2015 | 378 | 0.030 |
Why?
| | Gallbladder Emptying | 1 | 1992 | 1 | 0.030 |
Why?
| | Cell Line | 2 | 2015 | 2847 | 0.020 |
Why?
| | Gallbladder | 1 | 1992 | 19 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2022 | 5131 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 754 | 0.020 |
Why?
| | Cholecystectomy | 1 | 1992 | 62 | 0.020 |
Why?
| | Lithotripsy | 1 | 1992 | 48 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2015 | 696 | 0.020 |
Why?
| | Fibroblasts | 1 | 1976 | 996 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1250 | 0.020 |
Why?
| | Colonic Neoplasms | 1 | 1992 | 258 | 0.020 |
Why?
| | Liver | 1 | 2018 | 1943 | 0.020 |
Why?
| | Atenolol | 1 | 1988 | 7 | 0.020 |
Why?
| | Luteal Phase | 1 | 1988 | 45 | 0.020 |
Why?
| | Premenstrual Syndrome | 1 | 1988 | 34 | 0.020 |
Why?
| | Young Adult | 2 | 2019 | 13209 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 5079 | 0.020 |
Why?
| | Immunoglobulins | 1 | 2008 | 171 | 0.020 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2007 | 130 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2008 | 410 | 0.020 |
Why?
| | Pregnancy | 1 | 2018 | 6763 | 0.020 |
Why?
| | Depressive Disorder | 1 | 1988 | 379 | 0.010 |
Why?
| | Reference Values | 1 | 2006 | 816 | 0.010 |
Why?
| | Infant | 1 | 2018 | 9465 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2007 | 1142 | 0.010 |
Why?
| | Mice, Inbred CBA | 1 | 2001 | 54 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1946 | 0.010 |
Why?
| | Acetylgalactosamine | 1 | 2001 | 1 | 0.010 |
Why?
| | Glucosamine | 1 | 2001 | 13 | 0.010 |
Why?
| | Cyclooxygenase 1 | 1 | 2001 | 27 | 0.010 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 77 | 0.010 |
Why?
| | Interleukin-12 | 1 | 2001 | 121 | 0.010 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2001 | 124 | 0.010 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 162 | 0.010 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2001 | 173 | 0.010 |
Why?
| | Peptides | 1 | 2006 | 985 | 0.010 |
Why?
| | Cyclooxygenase 2 | 1 | 2001 | 178 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2001 | 240 | 0.010 |
Why?
| | Isoenzymes | 1 | 2001 | 304 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 283 | 0.010 |
Why?
| | Adolescent | 1 | 2019 | 21513 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2001 | 313 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 810 | 0.010 |
Why?
| | Double-Blind Method | 2 | 1998 | 1993 | 0.010 |
Why?
| | Manifest Anxiety Scale | 1 | 1998 | 4 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2001 | 1353 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2001 | 620 | 0.010 |
Why?
| | Cartilage, Articular | 1 | 2001 | 311 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2001 | 2057 | 0.010 |
Why?
| | NF-kappa B | 1 | 2001 | 691 | 0.010 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 1976 | 15 | 0.010 |
Why?
| | Phosphorylation | 1 | 2001 | 1759 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2001 | 915 | 0.010 |
Why?
| | Ascorbic Acid | 1 | 1976 | 177 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2001 | 1164 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2001 | 4193 | 0.010 |
Why?
| | Chenodeoxycholic Acid | 1 | 1992 | 16 | 0.010 |
Why?
| | Ursodeoxycholic Acid | 1 | 1992 | 21 | 0.010 |
Why?
| | Food | 1 | 1992 | 164 | 0.010 |
Why?
| | Fasting | 1 | 1992 | 281 | 0.010 |
Why?
| | Odds Ratio | 1 | 1992 | 1070 | 0.000 |
Why?
| | Renin | 1 | 1988 | 35 | 0.000 |
Why?
| | Aldosterone | 1 | 1988 | 45 | 0.000 |
Why?
| | Ultrasonography | 1 | 1992 | 759 | 0.000 |
Why?
| | Random Allocation | 1 | 1988 | 353 | 0.000 |
Why?
| | Progesterone | 1 | 1988 | 254 | 0.000 |
Why?
| | Incidence | 1 | 1992 | 2804 | 0.000 |
Why?
| | Estrogens | 1 | 1988 | 367 | 0.000 |
Why?
| | Clinical Trials as Topic | 1 | 1988 | 1050 | 0.000 |
Why?
| | Treatment Outcome | 1 | 1998 | 10811 | 0.000 |
Why?
| | Prospective Studies | 1 | 1992 | 7604 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1992 | 15657 | 0.000 |
Why?
|
|
Kuhn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|